Results 91 to 100 of about 13,064 (207)

Transduction of EphA2-negative cells expressing recombinant EphA2 with YSA peptide-containing Ads.

open access: yes, 2014
SK-MEL-28 cells transfected with EphA2 expression plasmid (pcDNA-EphA2) or control plasmid (pcDNA) were transduced with genomically fiber-modified Luc/GFP reporter viruses.
Dirk M. Nettelbeck (194449)   +11 more
core   +1 more source

Inhibition of HDACs-EphA2 Signaling Axis with WW437 Demonstrates Promising Preclinical Antitumor Activity in Breast Cancer

open access: yesEBioMedicine, 2018
Histone deacetylase inhibitors (HDACi) are small molecules targeting epigenetic enzymes approved for hematologic neoplasms, which have also demonstrated clinical activities in solid tumors.
Tao Zhang   +13 more
doaj   +1 more source

The EphA2 receptor drives self-renewal and tumorigenicity in stem-like tumor-propagating cells from human glioblastomas

open access: yes, 2012
In human glioblastomas (hGBMs), tumor-propagating cells with stem-like characteristics (TPCs) represent a key therapeutic target. We found that the EphA2 receptor tyrosine kinase is overexpressed in hGBM TPCs.
De Bonis, Pasquale   +36 more
core   +1 more source

Identification of therapeutic targets and prognostic biomarkers of the ephrin receptor subfamily in pancreatic adenocarcinoma

open access: yesJournal of International Medical Research
Objectives We aimed to examine the significance of ephrin receptor A2 (EphA2) expression in pancreatic adenocarcinoma (PAAD) and its associated mechanism.
Jingjing Zou   +4 more
doaj   +1 more source

HHV-8 gH/gL induces constitutive EphA2 dimerization.

open access: yes, 2021
The FSI-FRET data measured in HEK293T cells (S10 Fig) were fit to dimerization models to generate dimerization curves by plotting the calculated dimeric fraction as a function of the total EphA2 concentration (EphA2-mTurquoise + EphA2-eYFP).
Pablo Guardado-Calvo (2325709)   +8 more
core   +1 more source

EphA2 Targeted Doxorubicin-Nanoliposomes for Osteosarcoma Treatment

open access: yesPharmaceutical Research, 2017
To employ Doxorubicin-loaded liposomes, modified with YSA-peptide to target EphA2, to reduce adverse effects against primary bone cells and maximize toxicity against Saos-2 osteosarcoma cells.PEGylated liposomes were prepared by thin film method using Dipalmitoylphosphatidylcholine (DPPC), cholesterol and distearylphosphatidylethanolamine ...
Haghiralsadat, F.   +7 more
openaire   +6 more sources

COE targets EphA2 to inhibit vasculogenic mimicry formation induced by hypoxia in hepatocellular carcinoma

open access: yesFrontiers in Pharmacology
BackgroundVasculogenic Mimicry (VM) can reduce the efficacy of anti-angiogenesis and promote distant metastasis in hepatocellular carcinoma (HCC). Our previous studies have found that Celastrus orbiculatus extract (COE) can inhibit the VM formation in ...
Jue Chen   +13 more
doaj   +1 more source

Targeting EphA2 suppresses the proliferation, migration and invasion of endometriosis via the AMPK signaling pathway

open access: yesEuropean Journal of Histochemistry
Endometriosis is a benign disease with similar characteristics to tumors. Recent studies have found that the erythropoietin-producing hepatoma receptor A2 (EphA2) has the dual effect of promoting tumor and inhibiting tumor.
Chaoyi Yang   +4 more
doaj   +1 more source

Dimerization of EphA2 in Plasma Membranes

open access: yesThe FASEB Journal, 2015
EphA2 is a single pass transmembrane protein and a member of the largest Receptor Tyrosine Kinase (RTK) family. EphA2 regulates cell‐cell interactions during embryonic development in humans and is known as an oncoprotein as well as a tumor suppressor.
Kalina Hristova   +4 more
openaire   +1 more source

EPHA2 promotes SGC-7901 cell proliferation through enhancing Akt/mTOR signaling pathway

open access: yesZhongguo aizheng zazhi, 2016
Background and purpose: EPHA2 has been reported to enhance the proliferation of gastric cancer cells through promoting CyclinD1 expression and cell cycle progression.
李国栋, 王洋洋, 刘玉河
doaj  

Home - About - Disclaimer - Privacy